Earl G. Adams

962 total citations
26 papers, 819 citations indexed

About

Earl G. Adams is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Earl G. Adams has authored 26 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Earl G. Adams's work include Cancer therapeutics and mechanisms (9 papers), DNA Repair Mechanisms (3 papers) and Immune Cell Function and Interaction (3 papers). Earl G. Adams is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), DNA Repair Mechanisms (3 papers) and Immune Cell Function and Interaction (3 papers). Earl G. Adams collaborates with scholars based in United States, Nigeria and Canada. Earl G. Adams's co-authors include Bijoy K. Bhuyan, C. Bruce Bagwell, Li H. Li, Sheri L. Crampton, B. K. Bhuyan, Kathleen L. Rubino, Peter L. Collins, Sandra L. Kuentzel, Jane A. Gross and James P. Allison and has published in prestigious journals such as Journal of Virology, Annals of the New York Academy of Sciences and Journal of Cellular Physiology.

In The Last Decade

Earl G. Adams

23 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Earl G. Adams United States 13 360 257 100 99 91 26 819
Russell K. Young United States 11 533 1.5× 392 1.5× 125 1.3× 81 0.8× 179 2.0× 11 1.3k
M. Rieber Venezuela 16 550 1.5× 242 0.9× 109 1.1× 104 1.1× 126 1.4× 87 937
William B. McCombs United States 10 585 1.6× 418 1.6× 129 1.3× 66 0.7× 217 2.4× 15 1.1k
Masafumi Kudoh Japan 16 654 1.8× 260 1.0× 119 1.2× 50 0.5× 81 0.9× 28 1.1k
Hideji Fujii Japan 17 535 1.5× 623 2.4× 102 1.0× 55 0.6× 244 2.7× 22 1.1k
Ida Silvestri Italy 20 475 1.3× 412 1.6× 114 1.1× 100 1.0× 202 2.2× 46 1.1k
Sayed S. Daoud United States 17 459 1.3× 294 1.1× 37 0.4× 108 1.1× 94 1.0× 38 771
Bridget A. Quinn United States 16 454 1.3× 408 1.6× 168 1.7× 119 1.2× 110 1.2× 24 965
Erin Joseph United States 17 584 1.6× 228 0.9× 66 0.7× 47 0.5× 53 0.6× 31 985
James C. Stinson United States 9 558 1.6× 390 1.5× 128 1.3× 106 1.1× 204 2.2× 16 1.1k

Countries citing papers authored by Earl G. Adams

Since Specialization
Citations

This map shows the geographic impact of Earl G. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Earl G. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Earl G. Adams more than expected).

Fields of papers citing papers by Earl G. Adams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Earl G. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Earl G. Adams. The network helps show where Earl G. Adams may publish in the future.

Co-authorship network of co-authors of Earl G. Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Earl G. Adams. A scholar is included among the top collaborators of Earl G. Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Earl G. Adams. Earl G. Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Adams, Earl G., et al.. (2023). Efficacy of Azadirachta indica in the Treatment of Gastrointestinal Helminthiasis. Biotechnology Journal International. 27(5). 47–55.
3.
Adams, Earl G., et al.. (1995). Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin. Cancer Chemotherapy and Pharmacology. 35(6). 471–482. 13 indexed citations
4.
Adams, Earl G., et al.. (1995). Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin. Cancer Chemotherapy and Pharmacology. 35(6). 471–482.
5.
Adams, Earl G., et al.. (1994). V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant. Cancer Chemotherapy and Pharmacology. 34(1). 44–50. 5 indexed citations
6.
Bagwell, C. Bruce & Earl G. Adams. (1993). Fluorescence Spectral Overlap Compensation for Any Number of Flow Cytometry Parameters. Annals of the New York Academy of Sciences. 677(1). 167–184. 112 indexed citations
7.
Gramzinski, Robert, Earl G. Adams, Jane A. Gross, et al.. (1993). T cell receptor-triggered activation of intraepithelial lymphocytes in vitro. International Immunology. 5(2). 145–153. 51 indexed citations
8.
Adams, Earl G., et al.. (1993). Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemotherapy and Pharmacology. 32(3). 235–242. 249 indexed citations
9.
Bhuyan, Bijoy K., et al.. (1992). Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects. Cancer Chemotherapy and Pharmacology. 30(5). 348–354. 21 indexed citations
10.
Bhuyan, B. K., et al.. (1992). Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells.. PubMed. 52(20). 5687–92. 29 indexed citations
11.
Adams, Earl G., et al.. (1990). HPLC and Flow Cytometric Analyses of Uptake of Adriamycin and Menogaril by Monolayers and Multicell Spheroids. PubMed. 6(4). 153–166. 4 indexed citations
12.
Rubino, Kathleen L., et al.. (1990). Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins. Journal of Virology. 64(9). 4232–4241. 83 indexed citations
13.
Adams, Earl G., et al.. (1988). Effects of U-71,184 and several other CC-1065 analogues on cell survival and cell cycle of Chinese hamster ovary cells.. PubMed. 48(1). 109–16. 17 indexed citations
14.
Bhuyan, B. K., et al.. (1987). Colcemid effects on B16 melanoma cell progression and aberrant mitotic division. Journal of Cellular Physiology. 132(2). 237–245. 8 indexed citations
15.
Adams, Earl G. & Bijoy K. Bhuyan. (1986). Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.. PubMed. 46(12 Pt 1). 6125–30. 3 indexed citations
16.
Bhuyan, Bijoy K., et al.. (1986). Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture.. PubMed. 46(4 Pt 1). 1688–93. 81 indexed citations
17.
Bhuyan, B. K., Earl G. Adams, Mark Johnson, & Sheri L. Crampton. (1985). Synergistic combination of menogarol and melphalan and other two drug combinations. Investigational New Drugs. 3(3). 233–244. 2 indexed citations
18.
Bhuyan, Bijoy K., Sheri L. Crampton, & Earl G. Adams. (1983). Cell cycle effects of CC-1065.. PubMed. 43(9). 4227–32. 19 indexed citations
19.
Adams, Earl G., Sheri L. Crampton, & Bijoy K. Bhuyan. (1981). Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.. PubMed. 41(12 Pt 1). 4981–7. 20 indexed citations
20.
Adams, Earl G. & B. K. Bhuyan. (1980). Effects of 7-con-0-methylnogarol (7-omen) on cell progression of cho and l1210 cells in vitro and l1210 cells in vivo. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 283. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Russell K. Young Breakdown of academic impact, for papers by M. Rieber Breakdown of academic impact, for papers by William B. McCombs Breakdown of academic impact, for papers by Masafumi Kudoh Breakdown of academic impact, for papers by Hideji Fujii Breakdown of academic impact, for papers by Ida Silvestri Breakdown of academic impact, for papers by Sayed S. Daoud Breakdown of academic impact, for papers by Bridget A. Quinn Breakdown of academic impact, for papers by Erin Joseph Breakdown of academic impact, for papers by James C. Stinson
Rankless by CCL
2026